Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRPSARA study of ARA 290 for complex regional pain syndrome type 1
NL-OMON37009Phase 2Withdrawn
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Complex Regional Pain Syndrome Type 1 (CRPS-1) and Neuralgia comparing ARA 290 with Placebo (2 arms). Primary endpoints: Change in Numerical Rating Score of pain now and Global Health self-assessment. Planned start Sep 2012; status: withdrawn.
02
Drugs
cibinetide
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)Neuralgia
Beyond the preview
Go deeper on NL-OMON37009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37009.